As of 13 Nov 2026, Enginzyme has raised $22.3M across 1 verified round on record (amounts in other currencies converted to USD); latest: €21 million Series B, announced 22 Dec 2022.
Enginzyme sells enzyme-based biomanufacturing solutions for cleaner and more efficient manufacturing processes, targeting the biotech sector.
enginzyme.comLinkedInSolna, SwedenBiotechFounded 201430+ people
3 sources
Only one source was provided; it does not state a lead investor, valuation, financing total, or headquarters.
Publication audit: announced 2022-12-22: "22-Dec-2022" (https://www.bionity.com/en/news/1178983/swedish-startup-raises-21-million-to-accelerate-the-commercialisation-of-its-cell-free-biomanufacturing-technology.html)
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series B [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $22.3M €21 million | 2022-12-22 | not stated | No recent discussion |
3 sources [ VERIFIED · CORRECTED ] read against 1 of 3 sources Only one source was provided; it does not state a lead investor, valuation, financing total, or headquarters. Publication audit: announced 2022-12-22: "22-Dec-2022" (https://www.bionity.com/en/news/1178983/swedish-startup-raises-21-million-to-accelerate-the-commercialisation-of-its-cell-free-biomanufacturing-technology.html) | ||||
Checked against 10 sources on Sep 28
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Extension to its Series A financing round | n/a | 2021-02-11 | Industrifonden | |
Also named as backers in company research: Lotus One Investment Pte. Ltd.